Global Biomarkers Market: Information By Product (Consumables, Services, Software), By Type (Safety Biomarkers, Validation Biomarkers, Efficacy Biomarkers), By Application (Diagnostics, Personalized Medicine, Drug Discovery and Development, Disease Risk Assessment) and By Disease Indication (Cancer, Neurological Disorders, Cardiovascular Disorders, Immunological Disorders, Others) - Forecast till 2027
The global biomarkers market is expected to rise at a CAGR of 13.3% over the forecast period from 2016 to 2022, according to a new report from Market Research Future (MRFR). The report profiles the market’s key drivers and restraints in order to get a clear picture of the market’s progress over the coming years. Major players operating in the global biomarkers market are also assessed in the report to provide readers with a clear understanding of the competitive landscape of the market.
Biomarkers are identifiers of diseases manifested within the body by the body’s natural reaction with the respective disease. The global market for biomarkers has been mainly driven by the growing medical research sector around the world, including in developed countries such as France, the U.S., and Germany as well as emerging economies such as India, China, and Japan.
The growing prevalence of communicable diseases as well as chronic noncommunicable diseases, such as cancer, has been vital for the global medical biomarkers market in the last few years. This is likely to remain a key driver for the global biomarker market over the forecast period, as several countries have stepped up their efforts in the medical research sector due to the high profitability of the sector for the players involved in it. The increasing support from regulatory agencies such as the FDA is likely to be crucial for the biomarker market over the forecast period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1941
The growing prevalence of cancer is likely to be a major driver for the global biomarker market over the forecast period, as biomarkers play a vital role in the early diagnosis of cancer, which allows effective treatment. The growing government expenditure in cancer research is likely to be a major driver for the global biomarker market over the forecast period.
Segmentation:
The global biomarkers market is segmented on the basis of type, indication, application, and region.
The global biomarkers market has been segmented on the basis of type into predisposition biomarkers, diagnostic biomarkers, prognostic biomarkers, and predictive biomarkers.
On the basis of indication, the biomarkers market is segmented into cancer, neurological disorders, cardiovascular disorders, immunological disorders, and others.
On the basis of application, the biomarkers market is segmented into tests, therapies, drug discovery, drug formulation, and others.
Regional Analysis:
The global biomarkers market is segmented into North America, Europe, Asia Pacific, and the Middle East and Africa on the basis of region.
North America is the dominant regional revenue generator in the global biomarkers market and is likely to remain a leading force over the forecast period, with the regional market expected to grow at a CAGR of 13.6% over the forecast period. The strong presence of several leading players in the biomarkers market is likely to drive the market in North America. The presence of a stable medical research environment is also conducive to steady growth of the biomarkers market in North America over the forecast period. Cancer research is a well-funded endeavor in North America, with government agencies as well as private companies vying to come up with more effective biomarkers for diagnostic purposes. This is likely to be a major driver for the biomarkers market in North America over the forecast period.
Europe holds the second largest regional market share in the global biomarkers market and is likely to exhibit a 13.2% CAGR over the forecast period. The growing medical research sector in Central European countries such as France and Germany is likely to be a major driver for the biomarkers market in the region.
Asia Pacific is likely to exhibit rapid growth over the forecast period in the global biomarkers market due to the growing medical research sector in emerging southeast Asian countries such as India and China. The increasing prevalence of cancer in the region is also likely to drive the biomarkers market in the region over the forecast period.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/biomarker-market-1941
Competitive Analysis:
Merck & Co. Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Enzo Biochem Inc., PerkinElmer Inc., Siemens Healthcare GmbH, and Roche Diagnostics Ltd.
Industry Updates:
In February 2019, researchers at the Indian Institute of Technology in Rourkee identified salivary biomarkers for cancer. This represents a much easier alternative for diagnosis than conventional cancer diagnosis methods.
You may also be interested in...
Sports Medicine Market Information Global Forecast to 2027
Pediatric Brain Tumor Market Information Global Forecast Till 2027
Cancer Immunotherapy Market Research Report Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312